In response to: Steatotic liver disease-know your enemies

[...]as highlighted in the editorial, we found that the age at which MASLD/NAFLD is being diagnosed is trending younger, which suggests that the adverse liver effects of obesity and T2D are already being seen in the increasing prevalence rates of NAFLD/MASLD. [...]most of these therapies, outside of diet and exercise, are approved for adults and not children. [...]work must also continue on developing community interventions with community and school policy makers to create a healthy environment in which children can not only learn but be physically active and provided healthy food on a consistent basis. [...]only a very small percent of patients reported that the use of the terms “fatty’’ and “non-alcoholic” was stigmatizing compared to a majority of healthcare providers who thought these words caused discomfort and stigma among their patients [18]. Ethnic differences in the relationship between insulin sensitivity and insulin response: a systematic review and meta-analysis.